Mark Applebaum to High-Throughput Nucleotide Sequencing
This is a "connection" page, showing publications Mark Applebaum has written about High-Throughput Nucleotide Sequencing.
Connection Strength
0.201
-
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. Nat Med. 2022 08; 28(8):1581-1589.
Score: 0.159
-
Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma. JCO Precis Oncol. 2023 03; 7:e2200334.
Score: 0.042